Atlas Trials

Non-Interventional Study of Puzol-cel for CD19-Positive Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Clinical trial NCT07637929 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07637929
Sponsor
Chongqing Precision Biotech Co., Ltd
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (r/r B-ALL)
Start date
2026-06-01
Primary completion
2032-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.